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Abstract
Biomedical named entities often play impor-
tant roles in many biomedical text mining
tools. However, due to the incompleteness
of provided synonyms and numerous varia-
tions in their surface forms, normalization of
biomedical entities is very challenging. In this
paper, we focus on learning representations of
biomedical entities solely based on the syn-
onyms of entities. To learn from the incom-
plete synonyms, we use a model-based candi-
date selection and maximize the marginal like-
lihood of the synonyms present in top candi-
dates. Our model-based candidates are itera-
tively updated to contain more difficult neg-
ative samples as our model evolves. In this
way, we avoid the explicit pre-selection of
negative samples from more than 400K can-
didates. On four biomedical entity normal-
ization datasets having three different entity
types (disease, chemical, adverse reaction),
our model BIOSYN consistently outperforms
previous state-of-the-art models almost reach-
ing the upper bound on each dataset.
1 Introduction
Biomedical named entities are frequently used as
key features in biomedical text mining. From
biomedical relation extraction (Xu et al., 2016; Li
et al., 2017a) to literature search engines (Lee et al.,
2016), many studies are utilizing biomedical named
entities as a basic building block of their methodolo-
gies. While the extraction of the biomedical named
entities is studied extensively (Sahu and Anand,
2016; Habibi et al., 2017), the normalization of ex-
tracted named entities is also crucial for improving
the precision of downstream tasks (Leaman et al.,
2013; Wei et al., 2015).
†Corresponding authors
Unlike named entities from general domain text,
typical biomedical entities have several different
surface forms, making the normalization of biomed-
ical entities very challenging. For instance, while
two chemical entities ‘motrin’ and ‘ibuprofen’ be-
long to the same concept ID (MeSH:D007052),
they have completely different surface forms.
On the other hand, mentions having similar sur-
face forms could also have different meanings
(e.g. ‘dystrophinopathy’ (MeSH:D009136) and
‘bestrophinopathy’ (MeSH:C567518)). These ex-
amples show a strong need for building latent rep-
resentations of biomedical entities that capture se-
mantic information of the mentions.
In this paper, we propose a novel framework for
learning biomedical entity representations based on
the synonyms of entities. Previous works on entity
normalization mostly train binary classifiers that
decide whether the two input entities are the same
(positive) or different (negative) (Leaman et al.,
2013; Li et al., 2017b; Fakhraei et al., 2019; Phan
et al., 2019). Our framework called BIOSYN uses
the synonym marginalization technique, which
maximizes the probability of all synonym repre-
sentations in top candidates. We represent each
biomedical entity using both sparse and dense rep-
resentations to capture morphological and semantic
information, respectively. The candidates are itera-
tively updated based on our model’s representations
removing the need for an explicit negative sam-
pling from a large number of candidates. Also, the
model-based candidates help our model learn from
more difficult negative samples. Through extensive
experiments on four biomedical entity normaliza-
tion datasets, we show that BIOSYN achieves new
state-of-the-art performance on all datasets, out-
performing previous models by 0.8%∼2.6% top1
accuracy. Further analysis shows that our model’s
performance has almost reached the performance
upper bound of each dataset.
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The contributions of our paper are as follows:
First, we introduce BIOSYN for biomedical en-
tity representation learning, which uses synonym
marginalization dispensing with the explicit needs
of negative training pairs. Second, we show that the
iterative candidate selection based on our model’s
representations is crucial for improving the perfor-
mance together with synonym marginalization. Fi-
nally, our model outperforms strong state-of-the-art
models up to 2.6% on four biomedical normaliza-
tion datasets.1
2 Related Works
Biomedical entity representations have largely re-
lied on biomedical word representations. Right
after the introduction of Word2vec (Mikolov et al.,
2013), Pyysalo et al. (2013) trained Word2Vec on
biomedical corpora such as PubMed. Their biomed-
ical version of Word2Vec has been widely used
for various biomedical natural language process-
ing tasks (Habibi et al., 2017; Wang et al., 2018;
Giorgi and Bader, 2018; Li et al., 2017a) including
the biomedical normalization task (Mondal et al.,
2019). Most recently, BioBERT (Lee et al., 2019)
has been introduced for contextualized biomedi-
cal word representations. BioBERT is pre-trained
on biomedical corpora using BERT (Devlin et al.,
2019) and numerous studies are utilizing BioBERT
for building state-of-the-art biomedical NLP mod-
els (Lin et al., 2019; Jin et al., 2019; Alsentzer
et al., 2019; Sousa et al., 2019). Our model also
uses pre-trained BioBERT for learning biomedical
entity representations.
The intrinsic evaluation of the quality of biomed-
ical entity representations is often verified by
the biomedical entity normalization task (Leaman
et al., 2013; Phan et al., 2019). The goal of the
biomedical entity normalization task is to map an
input mention from a biomedical text to its asso-
ciated CUI (Concept Unique ID) in a dictionary.
The task is also referred to as the entity linking or
the entity grounding (D’Souza and Ng, 2015; Lea-
man and Lu, 2016). However, the normalization
of biomedical entities is more challenging than the
normalization of general domain entities due to a
large number of synonyms. Also, the variations
of synonyms depend on their entity types, which
makes building type-agnostic normalization model
difficult (Leaman et al., 2013; Li et al., 2017b; Mon-
dal et al., 2019). Our work is generally applicable
1Code available at https://github.com/dmis-lab/BioSyn.
to any type of entity and evaluated on four datasets
having three different biomedical entity types.
While traditional biomedical entity nor-
malization models are based on hand-crafted
rules (D’Souza and Ng, 2015; Leaman et al.,
2015), recent approaches for the biomedical
entity normalization have been significantly im-
proved with various machine learning techniques.
DNorm (Leaman et al., 2013) is one of the first
machine learning-based entity normalization
models, which learns pair-wise similarity using
tf-idf vectors. Another machine learning-based
study is CNN-based ranking method (Li et al.,
2017b), which learns entity representations using a
convolutional neural network. The most similar
works to ours are NSEEN (Fakhraei et al., 2019)
and BNE (Phan et al., 2019), which map mentions
and concept names in dictionaries to a latent space
using LSTM models and refines the embedding
using the negative sampling technique. However,
most previous works adopt a pair-wise training
procedure that explicitly requires making negative
pairs. Our work is based on marginalizing positive
samples (i.e., synonyms) from iteratively updated
candidates and avoids the problem of choosing a
single negative sample.
In our framework, we represent each entity with
sparse and dense vectors which is largely motivated
by techniques used in information retrieval. Models
in information retrieval often utilize both sparse and
dense representations (Ramos et al., 2003; Palangi
et al., 2016; Mitra et al., 2017) to retrieve relevant
documents given a query. Similarly, we can think
of the biomedical entity normalization task as re-
trieving relevant concepts given a mention (Li et al.,
2017b; Mondal et al., 2019). In our work, we use
maximum inner product search (MIPS) for retriev-
ing the concepts represented as sparse and dense
vectors, whereas previous models could suffer from
error propagation of the pipeline approach.
3 Methodology
3.1 Problem Definition
We define an input mention m as an entity string
in a biomedical corpus. Each input mention has
its own CUI c and each CUI has one or more syn-
onyms defined in the dictionary. The set of syn-
onyms for a CUI is also called as a synset. We
denote the union of all synonyms in a dictionary
as N = [n1, n2, . . . ] where n ∈ N is a single syn-
onym string. Our goal is to predict the gold CUI c∗
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Figure 1: The overview of BIOSYN. An input mention and all synonyms in a dictionary are embedded by a shared
encoder and the nearest synonym is retrieved by the inner-product. Top candidates used for training are iteratively
updated as we train our encoders.
of the input mention m as follows:
c∗ = CUI(argmaxn∈N P (n|m; θ)) (1)
where CUI(·) returns the CUI of the synonym n
and θ denotes a trainable parameter of our model.
3.2 Model Description
The overview of our framework is illustrated in Fig-
ure 1. We first represent each input mention m and
each synonym n in a dictionary using sparse and
dense representations. We treat m and n equally
and use a shared encoder for both strings. During
training, we iteratively update top candidates and
calculate the marginal probability of the synonyms
based on their representations. At inference time,
we find the nearest synonym by performing MIPS
over all synonym representations.
Sparse Entity Representation We use tf-idf to
obtain a sparse representation of m and n. We
denote each sparse representation as esm and e
s
n for
the input mention and the synonym, respectively.
tf-idf is calculated based on the character-level n-
grams statistics computed over all synonyms n ∈
N . We define the sparse scoring function of a
mention-synonym pair (m,n) as follows:
Ssparse(m,n) = f(e
s
m, e
s
n) ∈ R (2)
where f denotes a similarity function. We use the
inner product between two vectors as f .
Dense Entity Representation While the sparse
representation encodes the morphological infor-
mation of given strings, the dense representation
encodes the semantic information. Learning ef-
fective dense representations is the key challenge
in the biomedical entity normalization task (Li
et al., 2017b; Mondal et al., 2019; Phan et al.,
2019; Fakhraei et al., 2019). We use pre-trained
BioBERT (Lee et al., 2019) to encode dense rep-
resentations and fine-tune BioBERT with our syn-
onym marginalization algorithm.2 We share the
same BioBERT model for encoding mention and
synonym representations. We compute the dense
representation of the mention m as follows:
edm = BioBERT(m)[CLS] ∈ Rh (3)
where m = {m1, ...,ml} is a sequence of sub-
tokens of the mention m segmented by the Word-
Piece tokenizer (Wu et al., 2016) and h denotes
the hidden dimension of BioBERT (i.e., h = 768).
[CLS] denotes the special token that BERT-style
models use to compute a single representative
vector of an input. The synonym representation
edn ∈ Rh is computed similarly. We denote the
dense scoring function of a mention-synonym pair
(m,n) using the dense representations as follows:
Sdense(m,n) = f(e
d
m, e
d
n) ∈ R (4)
where we again used the inner product for f .
2We used BioBERT v1.1 (+ PubMed) in our work.
Similarity Function Based on the two similarity
functions Ssparse(m,n) and Sdense(m,n), we now
define the final similarity function S(m,n) indicat-
ing the similarity between an input mention m and
a synonym n:
S(m,n) = Sdense(m,n) + λSsparse(m,n) ∈ R
(5)
where λ is a trainable scalar weight for the sparse
score. Using λ, our model learns to balance the
importance between the sparse similarity and the
dense similarity.
3.3 Training
The most common way to train the entity represen-
tation model is to build a pair-wise training dataset.
While it is relatively convenient to sample positive
pairs using synonyms, sampling negative pairs are
trickier than sampling positive pairs as there are a
vast number of negative candidates. For instance,
the mention ‘alpha conotoxin’ (MeSH:D020916)
has 6 positive synonyms while its dictionary has
407,247 synonyms each of which can be a nega-
tive sampling candidate. Models trained on these
pair-wise datasets often rely on the quality of the
negative sampling (Leaman et al., 2013; Li et al.,
2017b; Phan et al., 2019; Fakhraei et al., 2019). On
the other hand, we use a model-based candidate
retrieval and maximize the marginal probability of
positive synonyms in the candidates.
Iterative Candidate Retrieval Due to a large
number of candidates present in the dictionary, we
need to retrieve a smaller number of candidates for
training. In our framework, we use our entity en-
coder to update the top candidates iteratively. Let
k be the number of top candidates to be retrieved
for training and α (0 ≤ α ≤ 1) be the ratio of
candidates retrieved from Sdense. We call α as the
dense ratio and α = 1 means consisting the can-
didates with Sdense only. First, we compute the
sparse scores Ssparse and the dense scores Sdense for
all n ∈ N . Then we retrieve the k − bαkc highest
candidates using Ssparse, which we call as sparse
candidates. Likewise, we retrieve the bαkc highest
candidates using Sdense, which we call as dense can-
didates. Whenever the dense and sparse candidates
overlap, we add more dense candidates to match
the number of candidates as k. While the sparse
candidates for a mention will always be the same
as they are based on the static tf-idf representation,
the dense candidates change every epoch as our
model learns better dense representations.
Our iterative candidate retrieval method has the
following benefits. First, it makes top candidates to
have more difficult negative samples as our model
is trained, hence helping our model represent a
more accurate dense representation of each entity.
Also, it increases the chances of retrieving previ-
ously unseen positive samples in the top candidates.
As we will see, comprising the candidates purely
with sparse candidates have a strict upper bound
while ours with dense candidates can maximize the
upper bound.
Synonym Marginalization Given the top candi-
dates from iterative candidate retrieval, we maxi-
mize the marginal probability of positive synonyms,
which we call as synonym marginalization. Given
the top candidates N1:k computed from our model,
the probability of each synonym is obtained as:
P (n|m; θ) = exp(S(n,m))∑
n′∈N1:k exp(S(n
′,m))
(6)
where the summation in the denominator is over the
top candidatesN1:k. Then, the marginal probability
of the positive synonyms of a mention m is defined
as follows:
P ′(m,N1:k) =
∑
n∈N1:k
EQUAL(m,n)=1
P (n|m; θ) (7)
where EQUAL(m,n) is 1 when CUI(m) is equiv-
alent to CUI(n) and 0 otherwise. Finally, we mini-
mize the negative marginal log-likelihood of syn-
onyms. We define the loss function of our model
as follows:
L = − 1
M
M∑
i=1
logP ′(mi, N1:k) (8)
where M is the number of training mentions in
our dataset. We use mini-batch for the training
and use Adam optimizer (Kingma and Ba, 2015)
to minimize the loss.
3.4 Inference
At inference time, we retrieve the nearest synonym
of a mention representation using MIPS. We com-
pute the similarity score S(m,n) between the in-
put mention m and all synonyms n ∈ N using
the inner product and return the CUI of the nearest
candidate. Note that it is computationally cheap to
find the nearest neighbors once we pre-compute the
dense and sparse representations of all synonyms.
4 Experimental Setup
4.1 Implementation Details
We perform basic pre-processings such as lower-
casing all characters and removing the punctuation
for both mentions and synonyms. To resolve the
typo issues in mentions from NCBI disease, we
apply the spelling check algorithm following the
previous work (D’Souza and Ng, 2015). Abbre-
viations of entities are widely used in biomedical
entities for an efficient notation which makes the
normalization task more challenging. Therefore,
we use the abbreviation resolution module called
Ab3P3 to detect the local abbreviations and ex-
pand it to its definition from the context (Sohn
et al., 2008). We also split composite mentions
(e.g. ’breast and ovarian cancer’) into separate
mentions (e.g. ’breast cancer’ and ’ovarian can-
cer’) using heuristic rules described in the previous
work (D’Souza and Ng, 2015). We also merge men-
tions in the training set to the dictionary to increase
the coverage following the previous work (D’Souza
and Ng, 2015).
For sparse representations, we use character-
level uni-, bi-grams for tf-idf. The maximum se-
quence length of BioBERT is set to 254 and any
string over the maximum length is truncated to 25.
The number of top candidates k is 20 and the dense
ratio α for the candidate retrieval is set to 0.5. We
set the learning rate to 1e-5, weight decay to 1e-2,
and the mini-batch size to 16. We found that the
trainable scalar λ converges to different values be-
tween 2 to 4 on each dataset. We train BIOSYN for
10 epochs for NCBI Disease, BC5CDR Disease,
and TAC2017 ADR and 5 epochs for BC5CDR
Chemical due to its large dictionary size. Except
the number of epochs, we use the same hyperpa-
rameters for all datasets and experiments.
We use the top k accuracy as an evaluation met-
ric following the previous works in biomedical en-
tity normalization tasks (D’Souza and Ng, 2015;
Li et al., 2017b; Wright, 2019; Phan et al., 2019;
Ji et al., 2019; Mondal et al., 2019). We define
Acc@k as 1 if a correct CUI is included in the top
k predictions, otherwise 0. We evaluate our models
using Acc@1 and Acc@5. Note that we treat pre-
dictions for composite entities as correct if every
prediction for each separate mention is correct.
3https://github.com/ncbi-nlp/Ab3P
4This covers 99.9% of strings in all datasets.
Dataset
Documents Mentions
Train Dev Test Train Dev Test
NCBI Disease 592 100 100 5,134 787 960
BC5CDR Disease 500 500 500 4,182 4,244 4,424
BC5CDR Chemical 500 500 500 5,203 5,347 5,385
TAC2017ADR 101 - 99 7,038 - 6,343
Table 1: Data statistics of four biomedical entity nor-
malization datasets. See Section 4.2 for more details of
each dataset.
4.2 Datasets
We use four biomedical entity normalization
datasets having three different biomedical entity
types (disease, chemical, adverse reaction). The
statistics of each dataset is described in Table 1.
NCBI Disease Corpus NCBI Disease Cor-
pus (Dog˘an et al., 2014)5 provides manually anno-
tated disease mentions in each document with each
CUI mapped into the MEDIC dictionary (Davis
et al., 2012). In this work, we use the July 6, 2012
version of MEDIC containing 11,915 CUIs and
71,923 synonyms included in MeSH and/or OMIM
ontologies.
Biocreative V CDR BioCreative V CDR (Li
et al., 2016)6 is a challenge for the tasks of
chemical-induced disease (CID) relation extrac-
tion. It provides disease and chemical type enti-
ties. The annotated disease mentions in the dataset
are mapped into the MEDIC dictionary like the
NCBI disease corpus. The annotated chemical
mentions in the dataset are mapped into the Com-
parative Toxicogenomics Database (CTD) (Davis
et al., 2018) chemical dictionary. In this work,
we use the November 4, 2019 version of the CTD
chemical dictionary containing 171,203 CUIs and
407,247 synonyms included in MeSH ontologies.
Following the previous work (Phan et al., 2019),
we filter out mentions whose CUIs do not exist in
the dictionary.
TAC2017ADR TAC2017ADR (Roberts et al.,
2017)7 is a challenge whose purpose of the task is
to extract information on adverse reactions found
in structured product labels. It provides manually
annotated mentions of adverse reactions that are
mapped into the MedDRA dictionary (Brown et al.,
1999). In this work, we use MedDRA v18.1 which
contains 23,668 CUIs and 76,817 synonyms.
5https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE
6https://biocreative.bioinformatics.udel.edu/tasks/biocreative-
v/track-3-cdr
7https://bionlp.nlm.nih.gov/tac2017adversereactions
Models
NCBI Disease BC5CDR Disease BC5CDR Chemical TAC2017ADR
Acc@1 Acc@5 Acc@1 Acc@5 Acc@1 Acc@5 Acc@1 Acc@5
Sieve-Based (D’Souza and Ng, 2015) 84.7 - 84.1 - 90.7† - 84.3† -
Taggerone (Leaman and Lu, 2016) 87.7 - 88.9 - 94.1 - - -
CNN Ranking (Li et al., 2017b) 86.1 - - - - - - -
NormCo (Wright, 2019) 87.8 - 88.0 - - - - -
BNE (Phan et al., 2019) 87.7 - 90.6 - 95.8 - - -
BERT Ranking (Ji et al., 2019) 89.1 - - - - - 93.2 -
TripletNet (Mondal et al., 2019) 90.0 - - - - - - -
BIOSYN (S-SCORE) 87.6 90.5 92.4 95.7 95.9 96.8 91.4 94.5
BIOSYN (D-SCORE) 90.7 93.5 92.9 96.5 96.6 97.2 95.5 97.5
BIOSYN (α = 0.0) 89.9 93.3 92.2 94.9 96.3 97.2 95.3 97.6
BIOSYN (α = 1.0) 90.5 94.5 92.8 96.0 96.4 97.3 95.8 97.9
BIOSYN (Ours) 91.1 93.9 93.2 96.0 96.6 97.2 95.6 97.5
† We used the author’s provided implementation to evaluate the model on these datasets.
Table 2: Experimental results on four biomedical entity normalization datasets
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Figure 2: Effect of iterative candidate retrieval on the development sets of NCBI Disease, BC5CDR Disease, and
BC5CDR Chemical. We show the recall of top candidates of each model.
5 Experimental Results
We use five different versions of our model to
see the effect of each module in our framework.
First, BIOSYN denotes our proposed model with
default hyperparameters described in Section 4.1.
BIOSYN (S-SCORE) and BIOSYN (D-SCORE) use
only sparse scores or dense scores for the predic-
tions at inference time, respectively. To see the
effect of different dense ratios, BIOSYN (α = 0.0)
uses only sparse candidates and BIOSYN (α = 1.0)
uses only dense candidates during training.
5.1 Main Results
Table 2 shows our main results on the four datasets.
Our model outperforms all previous models on
the four datasets and achieves new state-of-the-art
performance. The Acc@1 improvement on NCBI
Disease, BC5CDR Disease, BC5CDR Chemical
and TAC2017ADR are 1.1%, 2.6%, 0.8% and
2.4%, respectively. Training with only dense candi-
dates (α = 1.0) often achieves higher Acc@5 than
BIOSYN showing the effectiveness of dense candi-
dates.
5.2 Effect of Iterative Candidate Retrieval
In Figure 2, we show the effect of the iterative
candidate retrieval method. We plot the recall of
top candidates used in each model on the devel-
opment sets. The recall is 1 if any top candidate
has the gold CUI. BIOSYN (α = 1) uses only
dense candidates while BIOSYN (α = 0) uses
sparse candidates. BIOSYN utilizes both dense
and sparse candidates. Compared to the fixed re-
call of BIOSYN (α = 0), we observe a consistent
improvement in BIOSYN (α = 1) and BIOSYN.
This proves that our proposed model can increase
the upper bound of candidate retrieval using dense
representations.
5.3 Effect of the Number of Candidates
We perform experiments by varying the number of
top candidates used for training. Figure 3 shows
that a model with 20 candidates performs reason-
ably well in terms of both Acc@1 and Acc@5. It
shows that more candidates do not guarantee higher
performance, and considering the training complex-
ity, we choose k = 20 for all experiments.
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Figure 3: Performance of BIOSYN on the development
set of NCBI Disease with different numbers of candi-
dates
5.4 Effect of Synonym Marginalization
Our synonym marginalization method uses
marginal maximum likelihood (MML) as the ob-
jective function. To verify the effectiveness of our
proposed method, we compare our method with
two different strategies: hard EM (Liang et al.,
2018) and the standard pair-wise training (Leaman
et al., 2013). The difference between hard EM and
MML is that hard EM maximizes the probability of
a single positive candidate having the highest prob-
ability. In contrast, MML maximizes marginalized
probabilities of all synonyms in the top candidates.
For hard EM, we first obtain a target n˜ as follows:
n˜ = argmaxn∈N1:k P (n|m; θ) (9)
where most notations are the same as Equation 1.
The loss function of hard EM is computed as fol-
lows:
L = − 1
M
M∑
i=1
logP (n˜|mi; θ). (10)
The pair-wise training requires a binary classifi-
cation model. For the pair-wise training, we mini-
mize the binary cross-entropy loss using samples
created by pairing each positive and negative can-
didate in the top candidates with the input mention.
Table 3 shows the results of applying three different
loss functions on BC5CDR Disease and BC5CDR
Chemical. The results show that MML used in our
framework learns better semantic representations
than other methods.
6 Analysis
6.1 Iterative Candidate Samples
In Table 4, we list top candidates of BIOSYN from
the NCBI Disease development set. Although the
Methods
BC5CDR D. BC5CDR C.
Acc@1 Acc@5 Acc@1 Acc@5
MML 91.1 95.4 96.7 97.7
Hard EM 91.0 95.8 96.5 97.5
Pair-Wise Training 90.7 94.4 96.3 97.2
Table 3: Comparison of two different training meth-
ods on the development sets of BC5CDR Disease,
BC5CDR Chemical
initial candidates did not have positive samples due
to the limitation of sparse representations, candi-
dates at epoch 1 begin to include more positive
candidates. Candidates at epoch 5 include many
positive samples, while negative samples are also
closely related to each mention.
6.2 Error Analysis
In Table 5, we analyze the error cases of our model
on the test set of NCBI Disease. We manually
inspected all failure cases and defined the follow-
ing error cases in the biomedical entity normaliza-
tion task: Incomplete Synset, Contextual Entity,
Overlapped Entity, Abbreviation, Hypernym, and
Hyponym. Remaining failures that are difficult to
categorize are grouped as Others.
Incomplete Synset is the case when the surface
form of an input mention is very different from the
provided synonyms of a gold CUI and requires the
external knowledge for the normalization. Contex-
tual Entity denotes an error case where an input
mention and the predicted synonym are exactly the
same but have different CUIs. This type of error
could be due to an annotation error or happen when
the same mention can be interpreted differently de-
pending on its context. Overlapped Entity is an
error where there is an overlap between the words
of input mention and the predicted candidate. This
includes nested entities. Abbrevation is an error
where an input mention is in an abbreviated form
but the resolution has failed even with the external
module Ab3P. Hypernym and Hyponym are the
cases when an input mention is a hypernym or a
hyponym of the annotated entity.
Based on our analyses, errors are mostly due to
ambiguous annotations (Contextual Entity, Over-
lapped Entity, Hypernym, Hyponym) or failure of
pre-processings (Abbreviation). Incomplete Synset
can be resolved with a better dictionary having
richer synonym sets. Given the limitations in an-
notations, we conclude that the performance of
BIOSYN has almost reached the upper bound.
Rank tf-idf Epoch 0 Epoch 1 Epoch 5
prostate carcinomas (MeSH:D011471)
1 carcinomas prostatic cancers* prostate cancers* prostate cancers*
2 teratocarcinomas prostate cancers* prostatic cancers* prostate cancer*
3 pancreatic carcinomas ... glioblastomas prostate neoplasms* prostatic cancers*
4 carcinomatoses carcinomas prostate cancer* prostate neoplasms*
5 carcinomatosis renal cell cancers prostate neoplasm* prostatic cancer*
6 breast carcinomas renal cancers prostatic cancer* cancers prostate*
7 teratocarcinoma retinoblastomas prostatic neoplasms* prostate neoplasm*
8 carcinoma cholangiocarcinomas advanced prostate cancers* cancer of prostate*
9 breast carcinoma pulmonary cancers prostatic neoplasm* cancer of the prostate*
10 carcinosarcomas gonadoblastomas prostatic adenomas cancer prostate*
brain abnormalities (MeSH:D001927)
1 nail abnormalities brain dysfunction minimal brain pathology* brain disorders*
2 abnormalities nail brain pathology* brain disorders* brain disorder*
3 facial abnormalities deficits memory white matter abnormalities brain diseases*
4 torsion abnormalities memory deficits brain disease* brain disease*
5 spinal abnormalities neurobehavioral manifestations brain diseases* abnormalities in brain dev...
6 skin abnormalities white matter diseases brain disorder* nervous system abnormalities
7 genital abnormalities brain disease metabolic neuropathological abnormalities white matter abnormalities
8 nail abnormality neuropathological abnormalities brain dysfunction minimal metabolic brain disorders
9 clinical abnormalities neurobehavioral manifestation white matter lesions brain metabolic disorders
10 abnormalities in brain dev... brain disease* brain injuries brain pathology*
type ii deficiency (OMIM:217000)
1 mat i iii deficiency deficiency disease type ii c2 deficient* factor ii deficiency
2 naga deficiency type iii ... type 1 citrullinemia deficiency disease type ii c2 deficient*
3 properdin deficiency type iii ... cmo ii deficiency deficiency diseases factor ii deficiencies
4 properdin deficiency type i ... mitochondrial trifunctional ... type ii c2d deficiency* type ii c2d deficiency*
5 naga deficiency type iii type ii c2 deficient* factor ii deficiency diabetes mellitus type ii
6 naga deficiency type ii deficiency aga deficiency protein deficiency factor ii
7 properdin deficiency type iii sodium channel myotonia deficiency vitamin c2 deficiency*
8 properdin deficiency type ii deficiency diseases deficiency factor ii t2 deficiency
9 tc ii deficiency tuftsin deficiency deficiency arsa tc ii deficiency
10 si deficiency triosephosphate isomerase ... class ii angle mitochondrial complex ii ...
Table 4: Changes in the top 10 candidates given the two input mentions from the NCBI Disease development set.
Synonyms having correct CUIs are indicated in boldface with an asterisk.
Error Type Input Predicted Annotated Statistics
Incomplete Synset hypomania hypodermyiasis mood disorders 25 (29.4%)
Contextual Entity colorectal adenomas colorectal adenomas polyps adenomatous 3 (3.5%)
Overlapped Entity desmoid tumors desmoid tumor desmoids 11 (12.9%)
Abbreviation sca1 oca1 spinocerebellar ataxia 1 10 (11.8%)
Hypernym campomelia campomelic syndrome campomelia cumming type 10 (11.8%)
Hyponym eye movement abnormalities eye movement disorder eye abnormalities 23 (27.1%)
Others hamartoma syndromes hamartomas multiple hamartoma syndromes 3 (3.5%)
Table 5: Examples and statistics of error cases on the NCBI Disease test set
7 Conclusion
In this study, we introduce BIOSYN that utilizes
the synonym marginalization technique and the
iterative candidate retrieval for learning biomedical
entity representations. On four biomedical entity
normalization datasets, our experiment shows that
our model achieves state-of-the-art performance on
all datasets, improving previous scores up to 2.6%.
Although the datasets used in our experiments are
in English, we expect that our methodology would
work in any language as long as there is a synonym
dictionary for the language. For future work, an
extrinsic evaluation of our methods is needed to
prove the effectiveness of learned biomedical entity
representations and to prove the quality of the entity
normalization in downstream tasks.
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